• Chinese
Cover Image

Future Horizons and Growth Strategies in the French Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

2014 Strategies for the French Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  The report examines key French market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests

  • 1. AIDS
  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
  • 2. Adenovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
    • d. Adeno-Associated Viruses(AAV)
  • 3. Aeromonas
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 4. Anthrax/Bacillus Anthracis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 5. Arboviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 6. Babesiosis
    • a. Background
  • 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 8. Blastocystis Hominis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 9. Brucella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 10. Campylobacter
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 11. Candida
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 12. Chagas Disease
    • a. Background
  • 13. Chancroid
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 14. Chlamydia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 15. Clostridium Difficile
    • a. Background
    • b. Diagnostic Tests
    • c. Drugs and Vaccines
  • 16. Coronaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 17. Coxsackieviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 18. Creutzfeldt-Jakob's Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccine
  • 19. Cryptosporidium Parvum
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 20. Cyclospora Cayetanensis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 21. Cytomegalovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 22. Ebola Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 23. E. Coli
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 24. EchoVirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 25. Encephalitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 26. Enteroviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 27. Epstein-Barr Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 28. Giardia Lamblia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 29. Gonorrhea
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 30. Granuloma Inguinale
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 31. Hantavirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 32. Helicobacter Pylori
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 33. Hepatitis
    • a. Background
    • b. Hepatitis A
    • c. Hepatitis B
    • d. Hepatitis C
    • e. Vaccines and Drugs
  • 34. Herpes Simplex Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 35. Human Herpes Virus-6 (HHV-6)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 36. Influenza Viruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 37. Legionella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 38. Lyme Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 39. Lymphogranuloma Venereum (LGV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 40. Malaria
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 41. Measles (Rubeola)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 42. Meningitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 43. Microsporidium
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 44. Mononucleosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 45. Mumps
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 46. Mycoplasma
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 47. Papillomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 48. Parvovirus B19
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 49. Pneumonia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 50. Polyomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 51. Pseudomonas Aeruginosa
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 52. Rabies
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 53. Respiratory Syncytial Virus (RSV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 54. RhinoViruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 55. RotaVirus (REOVIRUS)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 56. Rubella(MEASLES)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 57. Salmonellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 58. Septicemia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 59. Shigellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 60. Staphylococcus Aureus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 61. Streptococci
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 62. Syphilis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 63. Toxoplasmosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 64. Trichomonas Vaginalis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 65. Tuberculosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 66. Vibrio
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 67. West Nile Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 68. Yersina
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketedby Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers

C. Emerging Diagnostic Technologies

  • 1. Molecular Diagnostics
  • 2. Monoclonal Antibodies
  • 3. Immunoassays
  • 4. Differential Light Scattering
  • 5. Information Technology
  • 6. Artificial Intelligence
  • 7. Liposomes
  • 8. Flow Cytometry
  • 9. Chromatography
  • 10. Diagnostic Imaging
  • 11. Gel Microdroplets
  • 12. Other

France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/Panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
  • France Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Laboratories Performing Infectious Disease Tests by Market Segment
  • France Hospital Laboratories Performing Infectious Disease Tests by Bed Size
  • France Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
  • France All Market Segments Infectious Disease Test Volume Forecast
  • France Hospital Laboratories Infectious Disease Test Volume Forecast
  • France Blood Banks Infectious Disease Test Volume Forecast
  • France Commercial/Private Laboratories Infectious Disease Test Volume Forecast
  • France All Market Segments Infectious Disease Diagnostics Market Forecast
  • France Hospital Laboratories Infectious Disease Diagnostics Market Forecast
  • France Blood Banks Infectious Disease Diagnostics Market Forecast
  • France Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
  • France HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HIV Ag Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
  • France BEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Candida Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Coxsackievirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • France CMV Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
  • France E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France EBV Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • France ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Measles Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Polyoma Viruses Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
  • France RSV Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France AIDS Testing Market Diagnostics Sales by Major Supplier
  • France Adenovirus Testing Market Diagnostics Sales by Major Supplier
  • France Campylobacter Testing Market Diagnostics Sales by Major Supplier
  • France Candida Testing Market Diagnostics Sales by Major Supplier
  • France Chlamydia Testing Market Diagnostics Sales by Major Supplier
  • France CMV Testing Market Diagnostics Sales by Major Supplier
  • France Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • France Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • France Hepatitis C Testing Market Diagnostics Sales by Major Supplier
  • France Herpes Testing Market Diagnostics Sales by Major Supplier
  • France Lyme Disease Testing Market Diagnostics Sales by Major Supplier
  • France Influenza Testing Market Diagnostics Sales by Major Supplier
  • France Meningitis Testing Market Diagnostics Sales by Major Supplier
  • France Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • France Mumps Testing Market Diagnostics Sales by Major Supplier
  • France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • France RSV Testing Market Diagnostics Sales by Major Supplier
  • France Rotavirus Testing Market Diagnostics Sales by Major Supplier
  • France Rubella Testing Market Diagnostics Sales by Major Supplier
  • France Septicemia Testing Market Diagnostics Sales by Major Supplier
  • France Shigella Testing Market Diagnostics Sales by Major Supplier
  • France Streptococci Testing Market Diagnostics Sales by Major Supplier
  • France Syphilis Testing Market Diagnostics Sales by Major Supplier
  • France Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
  • France Trichomonas Testing Market Diagnostics Sales by Major Supplier
  • France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Show More
RELATED REPORTS
* Future Horizons and Growth Strategies in the European Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 12800
  • 1600 Pages

* Future Horizons and Growth Strategies in the German Hospital Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 2900
  • 897 Pages

* Future Horizons and Growth Strategies in the German Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 4300
  • 983 Pages

* Future Horizons and Growth Strategies in the Japanese Hospital Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 3500
  • 891 Pages

* Future Horizons and Growth Strategies in the Japanese Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 5700
  • 976 Pages

* Future Horizons and Growth Strategies in the Spanish Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 4300
  • 960 Pages

* Future Horizons and Growth Strategies in the UK Hospital Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 2900
  • 886 Pages

* Future Horizons and Growth Strategies in the UK Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 4300
  • 978 Pages

* Future Horizons and Growth Strategies in the US Hospital Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 4400
  • 997 Pages

* Future Horizons and Growth Strategies in the US Microbiology Testing Market 2014: Supplier Shares and Country Forecasts
  • Published:
  • Aug 28, 2014
  • USD 6400
  • 1037 Pages

Browse more In Vitro Diagnostics Market Research Reports

Pricing